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single voxel. Test-retest measurements are a method to 
determine the smallest volume for which a reliable 
measurement can be obtained. A key asset of functional 
imaging is the capacity to measure physical quantities in 
tissue rather than contrast. In particular for longitudinal 
studies, monitoring treatment response, or in multi-center 
studies, this is critical. For radiotherapy dose painting it is 
necessary to know which threshold should be used to define a 
subvolume of the target for dose escalation. In the 
presentation, various quantitative methods and their 
reliability will be discussed. 
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Dynamic contrast-enhanced magnetic resonance imaging 
(DCE-MRI) is a technique based on rapid acquisition of a 
series of images depicting the uptake of a contrast agent (CA) 
in tissue. Through mathematical modeling of the CA’s 
influence on the MR signal and the distribution of CA in the 
tissue, physiological parameters can be obtained on a voxel 
by voxel level.  
These parameters, which for instance reflect flow, vessel 
integrity, cell and vessel density, are highly relevant in 
cancer treatments such as radiotherapy (RT). Several studies 
have shown that pretreatment parameter values as well as 
changes during RT can be correlated with outcome. However, 
drawing firm conclusions on the practical value of DCE-MRI in 
RT is currently difficult.  
The reason for this difficulty has its roots in the complexity 
of performing a DCE-MRI study. Obtaining accurate 
quantitative parameter values reflecting primarily the 
physiology of a tumor requires advanced imaging as well as 
complicated post processing. Unfortunately, even though 
state of the art acquisition and analysis is performed it is 
likely that influences from the precise acquisition settings 
and the analysis tools remain in the final result. Hence it is 
crucial that all variations during a study is minimized to 
maximize the sensitivity.  
Not only is it of great importance to reduce the variability 
within a study, ideally this should also be the case between 
studies. But here we have a significant issue. There are a 
large number of unavoidable trade-offs in DCE-MRI. For 
instance between spatial and temporal resolution and 
between accuracy, complexity and robustness of the analysis. 
Usually each group performing a study make their own 
decision on where to compromise and what parameters to 
evaluate. Although this may be optimal in each study it is 
problematic when drawing conclusions on the overall value of 
DCE-MRI in RT.  
Of this reason several authors are calling for standardization 
of DCE-MRI acquisition and analysis. One organization that 
has responded to this call is the Quantitative Imaging 
Biomarkers Alliance (QIBA) which has published guidelines for 
standardizing DCE-MRI. In a comparison of methodology in 
studies employing DCE-MRI in RT the results are mixed. 
Overall, the technical quality of studies, measured as 
compliance with QIBA guidelines, is improving with time. 
However, the spread is also increasing. Hopefully, in the 
future more people will adhere to the attempts to 
standardize DCE-MRI and thus enable more homogenous data 
which can be used for better answering how DCE-MRI can be 
employed to improve RT. 
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Over the last decade, Diffusion Weighted MRI(DWI) has 
emerged as a promising imaging technique in the field of 
radiation oncology.  
The ability of DWI to assess a tissue's microstructure makes it 
potentially very valuable in tumor characterization, 
delineation, detection of pathological lymph nodes, response 
prediction and response evaluation.  
However, acquisition, analysis and interpretation of the 
images is far from straightforward. The imaging technique is 
prone to distortions interfering with the accurate geometrical 
localisation and quantification of the tissue of interest. 
Furthermore quantification is heavily influenced by the 
choice of machine parameters, making reproducibility an 
important issue.  
Overcoming these problems is of the utmost importance to 
move DWI out of the realm of research and into daily 
practice.  
In this talk we will identify the important parameters 
influencing acquisition and quantification of DWI, with 
emphasis on the choice of b-values and geometrical 
accuracy. We will discuss the implications when using DWI for 
extracranial radiotherapy. Finally we will look into possible 
solutions and provide a framework to ensure maximal 
exploitation of the imaging technique for the future.  
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Increased use of small photon fields in stereotactic and 
intensity modulated radiotherapy has raised the need for 
standardizing the dosimetry of such fields using procedures 
consistent with those for conventional radiotherapy. While 
many problems of small field dosimetry have been raised in 
the past, e.g. in Report 103 of the Institute of Physics and 
Engineering in Medicine, a vast amount of literature has 
addressed most of those and solutions have been proposed 
for specific situations. What has hampered the development 
of a Code of Practice until recently was the availability of 
data but in the last few years a considerable number of 
publications have provided new data and insights that have 
enhanced our understanding of small field dosimetry. 
An international working group, established by the 
International Atomic Energy Agency (IAEA) in collaboration 
with the American Association of Physicists in Medicine 
(AAPM), has finalised a Code of Practice for the dosimetry of 
small static photon fields. The Code of Practice consists of six 
chapters and two appendices. The first chapter provides an 
introduction to situate the distinct role of this Code of 
Practice as compared to previous recommendations for 
reference dosimetry in external beam radiotherapy. The 
second chapter provides a brief discussion of the physics of 
small photon fields with emphasis on those aspects that are 
relevant to understanding the concepts of the Code of 
Practice. Particular issues that are addressed are the 
definition of field size, the field size dependent response of 
detectors, volume averaging, fluence perturbation 
corrections, reference conditions and beam quality in non-
conventional reference fields. The third chapter introduces 
all details of the formalism used, which is based on the IAEA-
AAPM formalism published by Alfonso et al. (Med Phys 
35:5179-5186, 2008) and is extended to clarify its application 
to flattening-filter-free beams (FFF beams). The fourth 
chapter provides a comprehensive overview of suitable 
dosimeters for reference dosimetry in the conventional 10 cm 
x 10 cm reference fields, for reference dosimetry in machine-
specific reference fields at machines that cannot establish a 
conventional 10 cm x 10 cm reference field and for the 
determination of field output factors in small fields. The fifth 
chapter gives practical recommendations for implementing 
reference dosimetry in both conventional 10 cm x 10 cm 
